TVRD

Tvardi Therapeutics, Inc. Common Stock
TVRD

Overview Fund Activity

121 hedge funds and large institutions have $45.6M invested in Tvardi Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
121
Holders Change
-15
Holders Change %
-11.03%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
35
Reduced
39
Closed
30
Calls
$132K
Puts
$49K
Net Calls
+$83K
Net Calls Change
-$207K

Top Buyers

1
IEFM
IQ EQ Fund Management
Ireland
+$1.28M
2
AQR Capital Management
AQR Capital Management
Connecticut
+$1.09M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$708K
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$436K
5
Charles Schwab
Charles Schwab
California
+$422K

Top Sellers

1
WP
Woodline Partners
California
-$1.79M
2
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$1.53M
3
E
Ergoteles
New York
-$1.01M
4
Bank of America
Bank of America
North Carolina
-$618K
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$566K
Name Holding Trade Value Shares
Change 		Shares
Change %
FBC
151
Fairfield, Bush & Co
Connecticut
– -$354 -3 Closed
FA
152
Fiduciary Alliance
South Carolina
– -$45 – –
3 4 5 6
7